- Home
- OIS vs MNPR Comparison
OIS vs MNPR Comparison
Compare OIS & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- MNPR
- Stock Information
- Founded
- OIS 1995
- MNPR 2014
- Country
- OIS United States
- MNPR United States
- Employees
- OIS N/A
- MNPR N/A
- Industry
- OIS Metal Fabrications
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- MNPR Health Care
- Exchange
- OIS Nasdaq
- MNPR Nasdaq
- Market Cap
- OIS 215.8M
- MNPR 229.2M
- IPO Year
- OIS 2001
- MNPR 2019
- Fundamental
- Price
- OIS $3.51
- MNPR $42.96
- Analyst Decision
- OIS Buy
- MNPR Strong Buy
- Analyst Count
- OIS 3
- MNPR 5
- Target Price
- OIS $6.17
- MNPR $59.50
- AVG Volume (30 Days)
- OIS 869.7K
- MNPR 24.1K
- Earning Date
- OIS 05-01-2025
- MNPR 05-08-2025
- Dividend Yield
- OIS N/A
- MNPR N/A
- EPS Growth
- OIS N/A
- MNPR N/A
- EPS
- OIS N/A
- MNPR N/A
- Revenue
- OIS $692,588,000.00
- MNPR N/A
- Revenue This Year
- OIS $3.39
- MNPR N/A
- Revenue Next Year
- OIS $6.66
- MNPR N/A
- P/E Ratio
- OIS N/A
- MNPR N/A
- Revenue Growth
- OIS N/A
- MNPR N/A
- 52 Week Low
- OIS $3.08
- MNPR $1.72
- 52 Week High
- OIS $5.86
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- OIS 35.28
- MNPR 61.68
- Support Level
- OIS $3.35
- MNPR $26.06
- Resistance Level
- OIS $3.67
- MNPR $40.90
- Average True Range (ATR)
- OIS 0.35
- MNPR 4.42
- MACD
- OIS -0.03
- MNPR 1.06
- Stochastic Oscillator
- OIS 19.82
- MNPR 91.91
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.